InMode: Discounted Valuation And Strong Fundamentals Make It A Buy

InMode Ltd. is rated a Buy, offering strong growth, innovation, global expansion, and attractive value. Learn more about INMD ...
Hosted on MSN

Canaccord Genuity Maintains InMode (INMD) Hold Recommendation

Fintel reports that on October 10, 2025, Canaccord Genuity maintained coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 8.62% Upside As of September 30, ...
Hosted on MSN

Needham Reiterates InMode (INMD) Hold Recommendation

Fintel reports that on October 10, 2025, Needham reiterated coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 4.31% Upside As of September 30, 2025, the ...
Investing

InMode (INMD) Stock Forecast & Price Target

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Seeking Alpha

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between ...

Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical ...